Every finding on record at Eden Home Health Care Inc

The following reflects the findings of the California Department of Public Health during a Recertification Survey at this location: 159 East Live Oak Avenue, Suite 205, Arcadia, California 91006. Representing the California Department of Public Health: Surveyor # , Health Facilities Evaluator Nurse Surveyor # 22303, Health Facilities Evaluator Nurse Unduplicated Admissions - 249 Sample Size - 7 Home Visits- 3

A review of all current medications CFR(s): 484.55(c)(5) A review of all medications the patient is currently using in order to identify any potential adverse effects and drug reactions, including ineffective drug therapy, significant side effects, significant drug interactions, duplicate drug therapy, and noncompliance with drug therapy. This ELEMENT is not met as evidenced by: Based on observation, interview and record review, the agency staff failed to ensure that patient's current medications taken are reviewed for accuracy and updated in the patient's medication profile for one of 7 patients (Patient 4). The deficient practice has the potential to result in medication errors and adverse actions that could affect the patient's health status. Findings: A review of Patient 4's clinical record indicated that the patient was admitted on 6/7/22, with diagnoses of polyarthritis (joint disease) and chronic calcinosis (accumulation of calcium salt crystals in the skin or muscles) of right knee. During the certification period of 6/7/22 through 8/5/22, the physician ordered for the skilled nurse to visit once a week for nine weeks. The skilled nurse was to assess all body systems including medication management. On 7/29/22, at 3:30 p.m., a joint home visit was conducted with LVN 1 at Patient 4's residence. Patient 4 was observed ambulating with the use of front wheel walker (FWW). Patient 4 was alert and verbally responsive. During a review of Patient 4's current medications taken by reconciling with the medication profile revealed Senna Oral (laxative- for constipation) 8.6 mg., two tablets daily was not available. Patient 4 stated she was not taking the medicine anymore. There was no documented evidence the attending physician was notified to discontinue the medicine. There was no documented evidence the medication profile was updated. On 7/31/22, at 11 a.m., DPCS stated it should have been documented the physician discontinued the medication and updated in the medication profile.